Navigation Links
Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc

WHIPPANY, N.J., Aug. 5 /PRNewswire/ -- Nexgen Spine, a leading developer of innovative spinal implants for the surgical treatment of degenerative disc disease, announced today that it has received CE mark approval to market the Physio-L(R) Lumbar Artificial Disc in the European Union.

"We are delighted that the Physio-L(R) Artificial Disc Prosthesis has received CE mark approval," said Alastair Clemow, Ph.D., President and CEO of Nexgen Spine. "This represents an important milestone in our plan to launch a full range of artificial disc prostheses based on our proprietary elastomeric disc technology." Dr. Clemow further added, "the fact that the Physio-L(R) is the first of the next generation elastomeric lumbar discs to receive a CE mark makes this approval even more exciting."

The Physio-L(R) Artificial Disc is an elastomeric disc prosthesis designed to be used in the lumbar spine for patients suffering from degenerative disc disease. The device's proprietary elastomeric technology enables the disc to closely mimic the mechanical properties of the natural disc and represents a significant advance over current designs of disc prostheses.

"The unique properties of the Physio-L(R) help restore the natural shock absorption of the disc," said Casey Lee MD, Chairman and Founder of Nexgen Spine. "This allows the surgeon to restore function to the patient's disc. The clinical data for the Physio-L(R) are demonstrating outstanding improvements in both patient disability and pain, supporting the concept of using elastomeric polymers for total disc prostheses."

Nexgen Spine, Inc. is dedicated to providing its customers with high quality products that promote pain relief, preservation of motion and restoration of function by applying state-of-the-art design, biomaterials, and manufacturing technology. The company, based in Whippany NJ, is ISO 13485:2003 certified.

Contact: Alastair Clemow, President & CEO at 973-386-1800 ext 302 (

SOURCE Nexgen Spine
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
2. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
3. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
4. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
5. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
6. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
9. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
10. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
11. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
Post Your Comments:
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):